Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
16.2 EUR | 0.00% | -1.82% | +92.86% |
Sales 2024 * | 123M 134M 182M | Sales 2025 * | 325M 354M 484M | Capitalization | 2.54B 2.77B 3.79B |
---|---|---|---|---|---|
Net income 2024 * | -430M -468M -640M | Net income 2025 * | -116M -126M -173M | EV / Sales 2024 * | 21.5 x |
Net Debt 2024 * | 89.28M 97.23M 133M | Net cash position 2025 * | 94.69M 103M 141M | EV / Sales 2025 * | 7.53 x |
P/E ratio 2024 * |
-5.99
x | P/E ratio 2025 * |
-32.5
x | Employees | 464 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 17.23% |
Latest transcript on MorphoSys AG
1 week | -1.82% | ||
Current month | -1.82% | ||
3 months | +1.25% | ||
6 months | +143.61% | ||
Current year | +92.86% |
Managers | Title | Age | Since |
---|---|---|---|
Jean-Paul Kress
CEO | Chief Executive Officer | 59 | 19-08-31 |
Lucinda Crabtree
DFI | Director of Finance/CFO | 45 | 23-08-06 |
Luisa Ciccarelli
CTO | Chief Tech/Sci/R&D Officer | - | 21-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Brosnan
BRD | Director/Board Member | 69 | 18-05-16 |
Director/Board Member | 67 | 18-05-16 | |
Marc Cluzel
CHM | Chairman | 69 | 12-05-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-06 | 16.2 | 0.00% | 0 |
24-06-05 | 16.2 | -4.71% | 0 |
24-06-04 | 17 | +3.03% | 0 |
24-06-03 | 16.5 | 0.00% | 30 |
24-05-31 | 16.5 | 0.00% | 0 |
Delayed Quote Deutsche Boerse AG, June 06, 2024 at 02:17 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+55.55% | 59.28B | |
+43.17% | 40.94B | |
-4.71% | 40.17B | |
-5.56% | 28.69B | |
+13.76% | 26.63B | |
-22.00% | 18.89B | |
+31.50% | 12.46B | |
+2.16% | 12.42B | |
+25.70% | 12.26B |
- Stock Market
- Equities
- MOR Stock
- MOR2 Stock